Dyne Therapeutics, Inc. ($DYN)

Apr 22, 26SELLRhodes Jason P· 150,942 sh @ $19.68−$2.97M↗

Apr 22, 26SELLRhodes Jason P· 75,866 sh @ $19.68−$1.49M↗

Apr 22, 26SELLRhodes Jason P· 59,663 sh @ $19.68−$1.17M↗

Apr 22, 26SELLKersten Dirk· director2,652 sh @ $20.00−$53K↗

Apr 22, 26SELLRhodes Jason P· 1,485 sh @ $19.68−$29K↗

Apr 21, 26SELLRhodes Jason P· 142,253 sh @ $19.51−$2.78M↗

Apr 21, 26SELLRhodes Jason P· 71,499 sh @ $19.51−$1.39M↗

Apr 21, 26SELLRhodes Jason P· 56,228 sh @ $19.51−$1.10M↗

Apr 21, 26SELLKersten Dirk· director8,300 sh @ $20.01−$166K↗

Apr 21, 26SELLRhodes Jason P· 1,530 sh @ $20.05−$31K↗

Apr 21, 26SELLRhodes Jason P· 1,398 sh @ $19.51−$27K↗

Apr 21, 26SELLRhodes Jason P· 769 sh @ $20.05−$15K↗

Apr 21, 26SELLRhodes Jason P· 605 sh @ $20.05−$12K↗

Apr 21, 26SELLRhodes Jason P· 15 sh @ $20.05−$301↗

Apr 20, 26SELLRhodes Jason P· 142,604 sh @ $20.06−$2.86M↗

Apr 20, 26SELLKersten Dirk· director125,274 sh @ $20.07−$2.51M↗

Apr 20, 26SELLRhodes Jason P· 71,676 sh @ $20.06−$1.44M↗

Apr 20, 26SELLRhodes Jason P· 56,368 sh @ $20.06−$1.13M↗

Apr 20, 26SELLRhodes Jason P· 1,401 sh @ $20.06−$28K↗

Apr 17, 26SELLKersten Dirk· director211,974 sh @ $20.29−$4.30M↗

$DYNDyne Therapeutics, Inc.